West Suffolk Hospital
Welcome,         Profile    Billing    Logout  
 1 Trial 
7 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Wood, Lisa
PROHIBIT-ICH, NCT03863665: Prevention of Hypertensive Injury to the Brain by Intensive Treatment of Blood Pressure After Intracerebral Haemorrhage

Terminated
N/A
86
Europe
A&D BP Digital Blood Pressure Monitor (UA-767PBT-Ci) CE Declaration UA-767PBT-Ci
University College, London, University of Oxford, The Stroke Association, United Kingdom
Intracerebral Hemorrhage
05/22
04/23
NCT05476913: GEKO Venous Thromboembolism Prevention Study

Recruiting
N/A
1200
Europe
geko™ device, geko, NMES
Firstkind Ltd, National Institute for Health Research, United Kingdom, Keele University, University Hospitals of North Midlands NHS Trust, University of California, Bournemouth University
Stroke, Acute, Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism
04/25
06/25
Azim, Abul
PROHIBIT-ICH, NCT03863665: Prevention of Hypertensive Injury to the Brain by Intensive Treatment of Blood Pressure After Intracerebral Haemorrhage

Terminated
N/A
86
Europe
A&D BP Digital Blood Pressure Monitor (UA-767PBT-Ci) CE Declaration UA-767PBT-Ci
University College, London, University of Oxford, The Stroke Association, United Kingdom
Intracerebral Hemorrhage
05/22
04/23
OPTIMAS, NCT03759938: OPtimal TIMing of Anticoagulation After Acute Ischaemic Stroke : a Randomised Controlled Trial

Active, not recruiting
N/A
3648
Europe
Direct oral anticoagulant (DOAC), dabigatran, apixaban, edoxaban, rivaroxaban
University College, London
Stroke, Acute, Atrial Fibrillation
05/24
10/24
NCT05476913: GEKO Venous Thromboembolism Prevention Study

Recruiting
N/A
1200
Europe
geko™ device, geko, NMES
Firstkind Ltd, National Institute for Health Research, United Kingdom, Keele University, University Hospitals of North Midlands NHS Trust, University of California, Bournemouth University
Stroke, Acute, Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism
04/25
06/25
Contact, First
PARTNER, NCT03150576: Platinum and Polyadenosine 5'Diphosphoribose Polymerisation Inhibitor for Neoadjuvant Treatment of Triple Negative Breast Cancer and/or Germline BRCA Positive Breast Cancer

Recruiting
2/3
780
Europe
Olaparib, Lynparza, Paclitaxel and Carboplatin, Taxol and Paraplatin
Cambridge University Hospitals NHS Foundation Trust, AstraZeneca, Cancer Research UK
Breast Cancer
06/24
06/34
Moody, Margaret
PARTNER, NCT03150576: Platinum and Polyadenosine 5'Diphosphoribose Polymerisation Inhibitor for Neoadjuvant Treatment of Triple Negative Breast Cancer and/or Germline BRCA Positive Breast Cancer

Recruiting
2/3
780
Europe
Olaparib, Lynparza, Paclitaxel and Carboplatin, Taxol and Paraplatin
Cambridge University Hospitals NHS Foundation Trust, AstraZeneca, Cancer Research UK
Breast Cancer
06/24
06/34

Download Options